Generate a tailored SOP for Dr. Samuel Katz. Improve your application with a focused, well-structured draft.
Samuel G. Katz is an Associate Professor of Pathology at Yale School of Medicine. He graduated with a combined B.S./M.S. from Yale University in 1995 and pursued dual M.D. and Ph.D. training in the Health Sciences & Technology program jointly administered by MIT and Harvard. His Ph.D. thesis, under Stuart H. Orkin, focused on transcriptional regulation in hematopoiesis. Dr. Katz completed residency and a fellowship in hematopathology at Brigham and Women’s Hospital. He has also performed post-doctoral studies on apoptosis in collaboration with Loren D. Walensky at the Dana Farber Cancer Institute. His laboratory concentrates on the intrinsic mechanisms of cell death and the ways to reprogram immunocytes to mediate extrinsic programmed cell death. As an active hematopathologist, he contributes to patient care while pursuing research focused on BCL-2 proteins, particularly their roles in cancer and apoptosis. Katz's interests span apoptosis, cell death, cellular reprogramming, endoplasmic reticulum stress, immunotherapy, and stem cells.
Yale School of Medicine • New Haven, CT
Management of laboratory focusing on cell death mechanisms and contributions to patient care as a hematopathologist.
GRE is optional for PhD applicants. TOEFL speaking scores below 26 or IELTS speaking below 7.5 may require summer English training.